SFRP4 and central nervous system cancer: We have shown previously in glioma and head and neck CSCs that sFRP4 inhibits the mesenchymal traits and promotes not only epithelial markers but also morphology (Warrier et al., 2014; Bhuvanalakshmi et al., 2015).